1 Recruiting Study of ARC-520 in Patients With HBeAg (Hepatitis B e Antigen) Positive Chronic Hepatitis B Virus
Condition: Chronic Hepatitis B
Interventions: Drug: ARC-520; Drug: Placebo; Drug: Entecavir; Drug: Tenofovir
4 Recruiting Study of ARC-520 in Patients With Chronic Hepatitis B Virus
Condition: Hepatitis B, Chronic
Interventions: Drug: ARC-520; Drug: Placebo
作者: newchinabok 时间: 2015-10-9 12:18
看1,4项进度作者: 阳光醉人 时间: 2015-10-9 17:03
1 Recruiting Study of ARC-520 in Patients With HBeAg (Hepatitis B e Antigen) Positive Chronic Hepatitis B Virus
Condition: Chronic Hepatitis B
Interventions: Drug: ARC-520; Drug: Placebo; Drug: Entecavir; Drug: Tenofovir
4 Recruiting Study of ARC-520 in Patients With Chronic Hepatitis B Virus
Condition: Hepatitis B, Chronic
Interventions: Drug: ARC-520; Drug: Placebo
1招募研究患者ARC-520 HBeAg(乙型肝炎e抗原)阳性的慢性乙型肝炎病毒
条件:慢性乙型肝炎
干预:药物:药物:药物ARC-520;安慰剂;:恩替卡韦;药物:泰诺福韦
4招聘研究慢性乙型肝炎患者ARC-520
条件:乙型肝炎,慢性
干预:药物:药物:安慰剂ARC-520;作者: newchinabok 时间: 2015-10-9 17:05
今年十月好像要完成一个试验作者: newchinabok 时间: 2015-10-9 17:08
First Received Date ICMJE May 15, 2015
试验1 Last Updated Date September 23, 2015
Start Date ICMJE May 2015
Estimated Primary Completion Date October 2015 (final data collection date for primary outcome measure作者: 相信会幸福 时间: 2015-10-9 17:11